Top Stock Gainers March 2025 - Monthly Performance Ranked
The top US-listed stocks of March 2025 by monthly gain, on split-adjusted closes. Ranks 3,909 companies above $100M on NYSE, Nasdaq and NYSE American.
Filter by sector or market cap, or find a symbol
2 stocks are withheld from this ranking because their price history is under review.
The gain covers the period; price, market cap, sector and country show each company as it is today.
Swipe or scroll the table sideways for more columns.
Rank
Symbol
Company Name
Mar Gain
Market Cap (today)
Price (today)
Country
Sector
1902
-5.19%
$303.50M
$10.28
United States
Financial Services
1908
-5.22%
$380.82M
$8.57
United States
Financial Services
1909
-5.23%
$1.31B
$13.15
United States
Financial Services
1919
-5.28%
$1.72B
$11.67
United States
Financial Services
1927
-5.30%
$283.58M
$10.35
United States
Financial Services
1929
-5.31%
$194.45M
$9.94
United States
Financial Services
1954
-5.47%
$521.59M
$7.75
United States
Financial Services
1955
-5.47%
$2.03B
$20.91
United States
Financial Services
1959
-5.48%
$263.92M
$13.37
United States
Financial Services
1969
-5.53%
$298.22M
$2.32
United States
Real Estate
1999
-5.66%
$433.04M
$21.67
United States
Financial Services
Top gain on this page
-5.19% CIVB
Rows on this page
100 ranks 1901–2000
Page
20 of 40
Period
March 2025 closed
Looking for a specific symbol?
52-WEEK LEADER
MGRT
+1,759%
Mega Fortune Company L..
2025 YTD LEADER
RGC
+16,054%
Regencell Bioscience H..
MAR 2025 LEADER
RGC
+593%
Regencell Bioscience H..
This ranking shows the top performing stocks and biggest stock gainers of March 2025, measured from the last close of February to the last close of March.
Monthly performance rankings can reveal price strength, sustained momentum, sector rotation, and event-driven moves that are not visible in one-day movers lists. The table is informational only and does not recommend any stock to buy, sell, or hold.
Gains are computed on split-adjusted closes, so a split inside the month does not read as a move. This ranking is informational and is not investment advice.